Table 5. Percentage of CD4+ and CD8+ T cells with effector/memory and central/memory phenotype in 18 TB patients at treatment completion.

	Patients		P value
	Group A (n = 8)	Group B (n = 10)
CD4+ T cells
TEM% (range)	21,27 (2,61–27,1)	41,7 (12,36–52,65)	0,001
TCM% (range)	2,36 (1,69–15,9)	15,82 (11,25–28,39)	0,003
CD8+ T cells
TEM% (range)	11,2 (5,6–21,4)	18,55 (12,5–35,6)	0,036
TCM% (range)	9,9 (3,1–14)	14 (6,7–22)	0,087

Abbreviations:

T_EM: T cells with an effector/memory phenotype, defined as CD45RO+/CCR7−.

T_CM: T cells with central/memory phenotype, defined as CD45RO+/CCR7+.

Group A: TB patients who had a QFT-G reversion (positive to negative) at the end of therapy.

Group B: TB patients who remained QFT-G positive at the end of therapy.